Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas
Clinical trial NCT05101148 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05101148
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-21
- Primary completion
- 2022-04-06
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.